1) Rabinovich GA, Liu FT, Hirashima M, et al. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol. 2007; 66(2-3): 143-58
|
|
|
2) Perillo NL, Pace KE, Baum LG, et al. Apoptosis of T cells mediated by galectin-1. Nature. 1995; 378: 736-9
|
|
|
3) Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med. 1998; 76: 402-12
|
|
|
4) Zick Y, Eisenstein M, Goren RA, et al. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J. 2004; 19(7-9): 517-26
|
|
|
5) Liu FT. Galectins: a new family of regulators of inflammation. Clin Immunol. 2000; 97: 79-88
|
|
|
6) Rabinovich GA, Baum LG, Tinari N, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 2002; 23: 313-20
|
|
|
7) Nishi N, Shoji H, Seki M, et al. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology. 2003; 13: 755-63
|
|
|
8) Kageshita T, Kashio Y, Yamauchi A, et al. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer. 2002; 99: 809-16
|
|
|
9) Irie A, Yamauchi A, Kontani K, et al. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res. 2005; 11: 2962-8
|
|
|
10) Matsumoto R, Hirashima M, Kita H, et al. Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol. 2002; 168: 1961-7
|
|
|
11) Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005; 6: 1245-52
|
|
|
12) Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007; 318: 1141-3
|
|
|
13) Kashio Y, Nakamura K, Abedin MJ, et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol. 2003; 170: 3631-6
|
|
|
14) Seki M, Sakata KM, Oomizu S, et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 2007; 56: 3968-76
|
|
|
15) Tanikawa R, Tanikawa T, Okada Y, et al. Interaction of galectin-9 with lipid rafts induces osteoblast proliferation through the c-Src/ERK signaling pathway. J Bone Miner Res. 2008; 23: 278-86
|
|
|
16) Arikawa T, Seki M, Sakara K, et al. Galectin-9 enhances chondrogenesis via TGF-beta signaling pathway. 20th IUBMB International Congress of Biochemistry and Molecular Biology and 11th FAOBMB Congress, 2006
|
|
|
17) Seki M, Oomizu S, Sakata KM, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol. 2008; 127: 78-88
|
|
|
18) Yamamoto H, Kashio Y, Shoji H, et al. Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol. 2007; 143 Suppl 1: 95-105
|
|
|
19) Katoh S, Ishii N, Nobumoto A, et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med. 2007; 176: 27-35
|
|
|
20) Niki T, Tsutsui S, Watanabe K, et al. Mast cell stabilizing effects of galectin-9. 20th IUBMB International Congress of Biochemistry and Molecular Biology and 11th FAOBMB Congress, 2006
|
|
|
21) 税田直樹, 有川智博, 塩田徹哉, 他. 過敏性肺臓炎モデルにおけるGalectin-9のTreg誘導とTh17抑制による病変形成抑制作用の検討. 第37回 日本免疫学会 (2007)
|
|
|
22) 有川智博, 積 正子, 渡邉浩大, 他. Galectin-9 ameliolates the severity of antibody-induced arthritis by inhibiting C5 cleavage. 第37回 日本免疫学会 (2007)
|
|
|
23) Tsuboi Y, Abe H, Nakagawa R, et al. Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing poly-morphonuclear leukocytes. Clin Immunol. 2007; 124: 221-33
|
|
|
24) 延本篤也, 大水総一, 竹下慶介, 他. NK細胞の活性化によるGalectin-9の抗腫瘍効果. 第37回 日本免疫学会 (2007)
|
|
|
25) 永原慶子, 延本篤也, 大水総一, 他. Galectin-9 prolong the survival of Meth A-bearing mice. 第37回 日本免疫学会(2007)
|
|
|